Mississippi · A9537

Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in Mississippi

Mississippi Medicare Avg
$30.65
11% below national avg
National Medicare Avg
$34.35
All states combined
Billed Charge (MS)
$263.29
What providers submit
Est. Commercial (MS)
$84.50
National avg: $97.11
Est. Cash / Self-Pay (MS)
$101.21
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

63
Services in MS
20
Providers
N/A
Min Payment
N/A
Max Payment

Mississippi Pricing in Context

In Mississippi, CPT code A9537 (Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries) carries an average Medicare payment of $30.65 — 11% below the national benchmark of $34.35. 20 providers across the state submitted claims for this procedure in 2023, performing 63 total services. Individual payments in MS ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Mississippi is $263.29, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Mississippi sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Medical Supplies procedures, the estimated commercial insurance price in Mississippi lands near $84.50, with self-pay cash prices typically around $101.21. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries cost in Mississippi?

The average Medicare payment for Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in Mississippi is $30.65, which is 11% below the national average of $34.35. Providers in MS typically bill $263.29 for this procedure.

What does Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries cost with insurance in Mississippi?

With commercial insurance in Mississippi, Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries costs an estimated $84.50. Without insurance, the estimated cash price is $101.21. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in Mississippi?

20 providers in Mississippi billed Medicare for Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries in 2023, performing 63 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries cheaper in Mississippi than the national average?

Yes — Technetium Tc-99m Mebrofenin, Diagnostic, Per Study Dose, Up To 15 Millicuries costs 11% below the national average in Mississippi. The state average Medicare payment is $30.65 compared to $34.35 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial